Intelligent Investor

Hansen increases earnings outlook

Hansen Technologies has upgraded its earnings guidance after a better than expected half.
By · 18 Dec 2015
By ·
18 Dec 2015 · 3 min read
Upsell Banner

Recommendation

Hansen Technologies Limited - HSN
Buy
below 2.20
Hold
up to 4.50
Sell
above 4.50
Buy Hold Sell Meter
HOLD at $3.07
Current price
$4.57 at 16:40 (19 April 2024)

Price at review
$3.07 at (18 December 2015)

Max Portfolio Weighting
4%

Business Risk
Medium-Low

Share Price Risk
Medium
All Prices are in AUD ($)

Hansen Technologies' share price has jumped 13% after the company announced a better than expected first half to the financial year and an improved outlook. Management initially expected revenue of $135m in 2016; however, it now believes the billing software maker will earn $72–74m in the six months to 31 December, nearly 50% higher than the same period last year.

What's more, operating margins are now expected to be 'at the top end' of the company's target range of 25–30%. 'If trading conditions remain favourable we would expect to broadly replicate these results in the second half of this financial year,' said chief executive Andrew Hansen. If that were the case, Hansen could expect to have around $42m in earnings before interest, tax, depreciation and amortisation (EBITDA) in 2016, a 61% increase on 2015.

Key Points

  • Favourable operating conditions in first half

  • Revenue and margin outlook improves

  • Raising price guide; Hold

Hansen has proven itself on many occasions to be a strong operator and has some decent competitive advantages thanks to high switching costs preventing its utility customers from easily switching providers.

Furthermore, Hansen and smaller competitor Gentrack are both likely to benefit from a worldwide trend towards privatising and deregulating utilities (see Gentrack: the captor, the spoils). Privatisation and deregulation tend to encourage more price points and product variety, which will force many utilities to upgrade their outdated internally developed systems. A more competitive retail environment requires flexible billing software capable of higher data loads – the specialty of Hansen and Gentrack.

Raising price guide

We're increasing our recommended Buy price from $1.70 to $2.20 and raising our Sell price from $3.00 to $4.50 to reflect the growing business and a more positive outlook.

It's worth noting that at $4.50, Hansen would have a market cap approaching $800m and a price-earnings ratio of around 30. Undoubtedly, that's a steep price, even for a high-quality company.

It's only reasonable to expect annual organic growth of 5–7% over the long term, or slightly higher given a few more cluey acquisitions (Hansen has a knack for them). At $4.50, total annual returns would probably only reach the mid to high single digits, so â€“ depending on what other opportunities you have on your plate â€“ you may want to gradually sell on the way up.

Nonetheless, Hansen has a lot going for it: decent competitive advantages, shareholder friendly management, a spotless balance sheet, recurring revenues, steady organic growth and the prospect of favourable acquisitions. We don't want to let go of Hansen too easily.

The share price is up 15% since Hansen: Result 2015 from 27 Aug 15 (Hold – $2.67) and has more than doubled since Hansen upgraded to Buy from 29 Oct 14 (Buy – $1.52). HOLD.

Note: The Intelligent Investor Growth portfolio owns shares in Hansen Technologies. You can find out about investing directly in Intelligent Investor and InvestSMART portfolios by clicking here.

Disclosure: The author owns shares in Hansen Technologies.

IMPORTANT: Intelligent Investor is published by InvestSMART Financial Services Pty Limited AFSL 226435 (Licensee). Information is general financial product advice. You should consider your own personal objectives, financial situation and needs before making any investment decision and review the Product Disclosure Statement. InvestSMART Funds Management Limited (RE) is the responsible entity of various managed investment schemes and is a related party of the Licensee. The RE may own, buy or sell the shares suggested in this article simultaneous with, or following the release of this article. Any such transaction could affect the price of the share. All indications of performance returns are historical and cannot be relied upon as an indicator for future performance.
Share this article and show your support

Join the Conversation...

There are comments posted so far.

If you'd like to join this conversation, please login or sign up here